Northwestern

Running trials

• Recruiting

  Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  NCT07057791· Phase 2· Source

• Recruiting

  A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  NCT07188558· Phase 3· Source

• Active, not recruiting

  Study of COYA 302 for the Treatment of ALS

  NCT07161999· Phase 2/3· Source

• Recruiting

  Treatment of Moderate to Severe Refractory Crohn's Disease

  NCT06721962· Phase 1/2· Source

• Recruiting

  Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

  NCT05289687· Phase 2· Source

• Recruiting

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  NCT04988555· Phase 1/2· Source

• Recruiting

  Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

  NCT04472338· Source

• Active, not recruiting

  PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

  NCT04089059· Source

• Active, not recruiting

  ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

  NCT03973372· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia2 recruiting
• Acute myeloid leukemia1 recruiting
• Childhood cancers1 recruiting
• Crohn's disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Lung cancer1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Prostate cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

  NCT05712694· Phase 3· Source

• Terminated

  A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

  NCT05070247· Phase 1/2· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Source

• Completed

  Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

  NCT04069312· Phase 3· Source

• Completed

  SVC Occlusion in Subjects With Acute Decompensated Heart Failure

  NCT03836079· Source